Matthew W Johnson Selected Research

Hallucinogens (Psychedelics)

1/2022	Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
1/2022	Psychedelics and health behaviour change.
12/2021	Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.
1/2021	Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.
1/2021	Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.
1/2019	Cessation and reduction in alcohol consumption and misuse after psychedelic use.
1/2019	Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
1/2019	Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.
1/2017	An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.
1/2015	Can psychedelic compounds play a part in drug dependence therapy?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew W Johnson Research Topics

Disease

17	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2014
11	Sexually Transmitted Diseases (Sexually Transmitted Disease) 12/2021 - 06/2012
6	Alcoholism (Alcohol Abuse) 01/2022 - 04/2013
5	Neoplasms (Cancer) 01/2021 - 12/2008
4	Opioid-Related Disorders (Opiate Addiction) 01/2019 - 11/2015
3	Cocaine-Related Disorders (Cocaine Addiction) 04/2020 - 03/2015
3	Pain (Aches) 01/2020 - 01/2016
3	Cognitive Dysfunction 10/2018 - 10/2006
3	Headache (Headaches) 04/2013 - 06/2012
3	Ulcerative Colitis 07/2010 - 01/2009
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2022 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2021
2	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 01/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 01/2015
2	Vomiting 01/2018 - 09/2012
2	Chronic Pain 01/2018 - 01/2016
2	HIV Infections (HIV Infection) 01/2016 - 11/2014
2	Celiac Disease (Celiac Sprue) 03/2012 - 12/2008
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2010 - 01/2009
2	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2006 - 01/2005
1	Gambling (Pathological Gambling) 01/2022
1	Obesity 01/2022
1	Feeding and Eating Disorders (Eating Disorder) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Treatment-Resistant Depressive Disorder 01/2021
1	Mental Disorders (Mental Disorder) 01/2020
1	Death (Near-Death Experience) 01/2019
1	Delirium 10/2018
1	Dizziness (Lightheadedness) 01/2018
1	Nausea 01/2018
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018
1	Anxiety Disorders (Anxiety Disorder) 07/2017
1	Paranoid Disorders (Paranoia) 12/2016
1	Communicable Diseases (Infectious Diseases) 11/2016
1	Narcolepsy 04/2013
1	Migraine Disorders (Migraine) 06/2012
1	Cluster Headache (Cluster Headaches) 06/2012
1	Pouchitis 07/2010
1	Osteoporosis 02/2010
1	Lymphoma (Lymphomas) 12/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2006

Drug/Important Bio-Agent (IBA)

17	Psilocybin (Psilocibin)IBA 01/2022 - 06/2012
13	Hallucinogens (Psychedelics)IBA 01/2022 - 09/2012
9	Pharmaceutical PreparationsIBA 04/2022 - 09/2012
7	Cocaine (Cocaine HCl)IBA 01/2022 - 06/2012
6	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2014
3	Lysergic Acid Diethylamide (LSD)IBA 01/2019 - 01/2016
2	Methamphetamine (Desoxyn)FDA LinkGeneric 04/2022 - 01/2022
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2018
2	Hypnotics and Sedatives (Sedatives)IBA 04/2013 - 01/2005
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2022
1	4-toluenesulfonyl fluoride (TSF)IBA 12/2021
1	Cycloserine (Seromycin)FDA Link 04/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018
1	Nicotine FDA Link 01/2016
1	Topiramate (Topamax)FDA LinkGeneric 03/2015
1	Methadone (Dolophine)FDA LinkGeneric 03/2015
1	Ketamine FDA LinkGeneric 01/2015
1	Ibogaine (Endabuse)IBA 01/2015
1	Therapeutic UsesIBA 11/2014
1	4-hydroxybutyric acidIBA 04/2013
1	Ethanol (Ethyl Alcohol)IBA 04/2013
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 04/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2012
1	16S Ribosomal RNAIBA 07/2010
1	MT2 Melatonin ReceptorIBA 10/2006
1	ramelteon (Rozerem)FDA Link 10/2006
1	LigandsIBA 01/2005
1	Histamine Antagonists (Antihistamines)IBA 01/2005
1	BarbituratesIBA 01/2005
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2005
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2005

Therapy/Procedure

13	Condoms (Condom) 12/2021 - 06/2012
4	Therapeutics 01/2021 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
3	Restorative Proctocolectomy 07/2010 - 01/2009
2	Gluten-Free Diet 03/2012 - 12/2008
1	Cognitive Training 11/2015
1	Colectomy 01/2009
1	Elective Surgical Procedures 01/2009
1	Hysterectomy 06/2006
1	Radiotherapy 06/2006